Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Botulinum Toxin Type A Versus Local Anesthetic Injection for Chronic Neuroma Pain After Combat-Related Amputation: A Multicenter Randomized Double-Blind Trial

NCT07626983 is registered in ClinicalTrials.gov with Ukrainian Society of Regional Anesthesia and Pain Therapy as lead sponsor.

NCT NCT07626983
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07626983 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Botulinum Toxin Type A Versus Local Anesthetic Injection for Chronic Neuroma Pain After Combat-Related Amputation: A Multicenter Randomized Double-Blind Trial
Lead sponsor
Ukrainian Society of Regional Anesthesia and Pain Therapy
Phase
Not applicable
Overall status
Not yet recruiting
Start date
May 30, 2026
Completion date
December 15, 2026
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic pain due to injury, combat related symptoms, neural injury, neuroma of lower limb, neuroma of upper limb